ICG dye imaging during surgery to check tumor edges
Treatments studied
Part of Cancer clinical trials.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a benign or malignant bone or soft-tissue mass planned for surgery at this hospital during the study time period
- You must be able to consent to the study
- You should not be pregnant or breastfeeding
- You should not have had a severe allergic reaction (anaphylaxis) to IV contrast or iodine
- Your kidney function must be good enough that your doctor clears you to receive ICG
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
This early-phase study tests whether a special dye can help doctors see a tumor more clearly during surgery in children and young people. If you have a solid tumor or certain lymphomas that need removal, the dye may help guide the surgeon to the right tissue.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
Hear when a new Benign Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.